Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Shields

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Cancer Research|March 8, 2000
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancerT A Lehman, B G Haffty, C J Carbone, et al.
Epidemiology (Cambridge, Mass.)|November 3, 1998
Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1P Mendola, K B Moysich, J L Freudenheim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1993
Lung cancer, race, and a CYP1A1 genetic polymorphismP G Shields, N E Caporaso, R T Falk, et al.
Cancer Research|August 28, 2001
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lungS P Hussain, P Amstad, K Raja, et al.
Cancer Research|February 11, 1999
Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancerC B Ambrosone, J L Freudenheim, P A Thompson, et al.
The Pharmacogenomics Journal|March 10, 2004
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialC Lerman, E P Wileyto, F Patterson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 1999
Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer riskK B Moysich, P G Shields, J L Freudenheim, et al.
Journal of the National Cancer Institute|June 7, 1995
Mutagens from heated Chinese and U.S. cooking oilsP G Shields, G X Xu, W J Blot, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogensA M Pfeifer, K E Cole, D T Smoot, et al.
Cancer Research|January 27, 1998
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progressionS Ambs, W G Merriam, W P Bennett, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|March 8, 2000
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancerT A Lehman, B G Haffty, C J Carbone, et al.
Epidemiology (Cambridge, Mass.)|November 3, 1998
Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1P Mendola, K B Moysich, J L Freudenheim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1993
Lung cancer, race, and a CYP1A1 genetic polymorphismP G Shields, N E Caporaso, R T Falk, et al.
Cancer Research|August 28, 2001
Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lungS P Hussain, P Amstad, K Raja, et al.
Cancer Research|February 11, 1999
Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancerC B Ambrosone, J L Freudenheim, P A Thompson, et al.
The Pharmacogenomics Journal|March 10, 2004
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialC Lerman, E P Wileyto, F Patterson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 1999
Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer riskK B Moysich, P G Shields, J L Freudenheim, et al.
Journal of the National Cancer Institute|June 7, 1995
Mutagens from heated Chinese and U.S. cooking oilsP G Shields, G X Xu, W J Blot, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogensA M Pfeifer, K E Cole, D T Smoot, et al.
Cancer Research|January 27, 1998
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progressionS Ambs, W G Merriam, W P Bennett, et al.
Pageof 9